The Autoimmune Disease Epidemic in Belgium
Autoimmune diseases (rheumatoid arthritis, systemic ginger lupus erythematosus, multiple sclerosis, crohn-mici-intestin-inflammatoire">ginger Crohn's disease, thyroide-hashimoto-hypothyroidie">ginger Hashimoto's thyroiditis, type 1 diabetes...) affect ~7-8% of the Belgian population and their prevalence increases annually by 3-9% since 1970. This increase strongly correlates with the increased consumption of liquid sugar and ultra-processed foods.
The Central Mechanism: Leaky Gut → Auto-ginger Immunity
1. Sugar → Disruption of Intestinal Tight Junctions
Tight junctions of the intestinal epithelium form a selective barrier. Core proteins (occludin, claudin-1, ZO-1) are degraded by chronic exposure to fructose and excess glucose. Chronic sugar consumption reduces occludin expression by 40-60%.
2. LPS → Activation of Dendritic Cells → Autoimmunity
LPS (lipopolysaccharides) from gram-negative gut bacteria that pass through the compromised barrier activate TLR4 receptors of dendritic cells. These activated dendritic cells present self-antigens to T-lymphocytes, which can trigger an autoimmune response by breaking central tolerance.
3. Fructose → Th17 Polarization → Autoimmune Inflammation
Fructose-activated hepatic ChREBP generates increased production of IL-6 and IL-23, cytokines that direct naive T-lymphocytes towards the pro-inflammatory Th17 profile — at the expense of the Treg (regulatory, tolerogenic) profile. Th17 excess and Treg deficiency are the immunological hallmarks of most autoimmune diseases.
INTI's Protective Mechanisms on Autoimmunity
| INTI Mechanism | Effect on Autoimmunity | Substance |
|---|---|---|
| Protection of tight junctions | Maintenance of intestinal barrier → ↓ translocated LPS | Gingerols/shogaols |
| Blocking TLR4/LPS signaling | ↓ activation of dendritic cells → ↓ breach of tolerance | [6]-shogaol |
| Systemic NF-κB inhibition | ↓ pro-autoimmune cytokines (IL-6, IL-17, TNF-α) | Gingerols/shogaols |
| Th17/Treg modulation | Rebalancing towards tolerogenic Treg profile | Paradols (in vitro) |
FAQ — INTI and Autoimmune Diseases Belgium
Can INTI treat an established autoimmune disease?
No. INTI is not an immunosuppressant. Established autoimmune diseases (arthritis, lupus, MS) require specialized medical treatment. INTI can be a relevant anti-inflammatory-science-utilisation">ginger anti-inflammatory dietary supplement as an adjunct to medical treatment.
Can sugar-free ginger shots interact with immunosuppressants?
Yes, potentially — ginger can modulate NF-κB, a target of certain immunosuppressants. Consult your rheumatologist or immunologist if you are on methotrexate, biologics (anti-TNF), or chronic corticosteroids.
Related Articles
Read more about related topics:
- Ginger and autoimmune diseases: rheumatoid arthritis, lupus, MS — NF-κB, Treg and pro-inflammatory sugar
- INTI and the immune system: sugary drinks weaken your defense — ginger as an immune stimulant
- INTI and ginger skin: how sugary drinks cause acne — ginger as a skin-friendly solution
- INTI and gut microbiome: why sugary drinks destroy your flora — ginger as a restorer
- Rheumatoid arthritis in Belgium: sugar, RANKL and ginger (2025)
- Systemic lupus erythematosus in Belgium: how sugar exacerbates autoimmune inflammation and why ginger helps
- Rheumatoid arthritis in Belgium: sugary drinks, joint inflammation and ginger as an immunomodulator
- INTI and ginger tinnitus (ear buzzing): how sugary and caffeinated drinks worsen tinnitus in Belgium